Scott Koenig
57Patents
20h-index
39Co-inventors
88Inventor score
Filing activity: May 5, 1994 → Jan 13, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6280667A | Process for making thermoplastic-biofiber composite materials and articles including a poly(vinylchloride) component | Performing Operations; Transporting | 90 | Expired |
| US7425619B2 | FcγRIIB specific antibodies and methods of use thereof | Chemistry; Metallurgy | 89 | Expired |
| US6818216B2 | Anti-RSV antibodies | Chemistry; Metallurgy | 84 | Expired |
| US8946387B2 | FcγRIIB specific antibodies and methods of use thereof | Chemistry; Metallurgy | 79 | Active |
| US8193318B2 | FcγRIIB specific antibodies and methods of use thereof | Chemistry; Metallurgy | 66 | Active |
| US7425620B2 | FcγRIIB-specific antibodies and methods of use thereof | Chemistry; Metallurgy | 63 | Expired |
| US8216574B2 | Engineering Fc antibody regions to confer effector function | Chemistry; Metallurgy | 55 | Active |
| US8187593B2 | FcγRIIB specific antibodies and methods of use thereof | Chemistry; Metallurgy | 52 | Active |
| US7229619B1 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 46 | Expired |
| US6855493B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 45 | Expired |
| US8044180B2 | FcγRIIB specific antibodies and methods of use thereof | Chemistry; Metallurgy | 44 | Active |
| US7323172B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 33 | Expired |
| US7553489B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 32 | Active |
| US7179900B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 31 | Expired |
| US6689369B2 | Immunogenic pneumococcal protein and vaccine compositions thereof | Human Necessities | 30 | Expired |
| US6565849B2 | Methods of enhancing activity of vaccines and vaccine compositions | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6833356B1 | Pneumococcal protein homologs and fragments for vaccines | Chemistry; Metallurgy | 26 | Expired |
| US8652466B2 | Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting | Chemistry; Metallurgy | 26 | Active |
| US7635568B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 26 | Expired |
| US7847082B2 | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment | Chemistry; Metallurgy | 23 | Active |
| US8663634B2 | Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity | Chemistry; Metallurgy | 18 | Active |
| US6503511B1 | Derivatives of choline binding proteins for vaccines | Human Necessities | 16 | Expired |
| US8800907B2 | Mobile device case with retractor reel assembly for user-provided headphones | Electricity | 16 | Active |
| US8530627B2 | FcγRIIB specific antibodies and methods of use thereof | Chemistry; Metallurgy | 13 | Active |
| US10160806B2 | Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.